BD named Vitor Roque as chief financial officer Thursday, ending the medtech company’s seven-month search for a permanent ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
BD (NYSE:BDX) today announced the appointment of a new CFO alongside Street-beating second-quarter financial results.
StockStory.org on MSN
BD’s (NYSE:BDX) Q1 CY2026 sales beat estimates
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced in Q1 CY2026, with sales up 5.2% year on year ...
Medical Device Network on MSN
BD uplifts FY26 revenue outlook based on steady portfolio performance
The uplifted FY26 outlook reflects a reversal on Q1 FY26, in which BD trimmed its outlook due to impacts from the sale of its ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results